These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25855934)

  • 1. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
    Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut barrier in health and disease: focus on childhood.
    Viggiano D; Ianiro G; Vanella G; Bibbò S; Bruno G; Simeone G; Mele G
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1077-85. PubMed ID: 25855935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeostasis of the gut barrier and potential biomarkers.
    Wells JM; Brummer RJ; Derrien M; MacDonald TT; Troost F; Cani PD; Theodorou V; Dekker J; Méheust A; de Vos WM; Mercenier A; Nauta A; Garcia-Rodenas CL
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G171-G193. PubMed ID: 27908847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of gastrointestinal bacterial overgrowth.
    Husebye E
    Chemotherapy; 2005; 51 Suppl 1():1-22. PubMed ID: 15855746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea.
    Lopetuso L; Graziani C; Guarino A; Lamborghini A; Masi S; Stanghellini V
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):873-883. PubMed ID: 28272692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut barrier: new acquisitions and therapeutic approaches.
    Scaldaferri F; Pizzoferrato M; Gerardi V; Lopetuso L; Gasbarrini A
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S12-7. PubMed ID: 22955350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?
    Scaldaferri F; Lopetuso LR; Petito V; Cufino V; Bilotta M; Arena V; Stigliano E; Maulucci G; Papi M; Emiliana CM; Poscia A; Franceschi F; Delogu G; Sanguinetti M; Spirito MD; Sgambato A; Gasbarrini A
    United European Gastroenterol J; 2014 Apr; 2(2):113-22. PubMed ID: 24918016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mucoprotectants in the management of gastrointestinal disorders.
    Eutamene H; Beaufrand C; Harkat C; Theodorou V
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):83-90. PubMed ID: 28946778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gastrointestinal microbiome - functional interference between stomach and intestine.
    Lopetuso LR; Scaldaferri F; Franceschi F; Gasbarrini A
    Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):995-1002. PubMed ID: 25439066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundance and diversity of GI microbiota rather than IgG4 levels correlate with abdominal inconvenience and gut permeability in consumers claiming food intolerances.
    Hippe B; Remely M; Bartosiewicz N; Riedel M; Nichterl C; Schatz L; Pummer S; Haslberger A
    Endocr Metab Immune Disord Drug Targets; 2014 Mar; 14(1):67-75. PubMed ID: 24502607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.
    Natividad JM; Verdu EF
    Pharmacol Res; 2013 Mar; 69(1):42-51. PubMed ID: 23089410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
    Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
    Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaky gut - concept or clinical entity?
    Quigley EM
    Curr Opin Gastroenterol; 2016 Mar; 32(2):74-9. PubMed ID: 26760399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of gastrointestinal toxicology.
    Coruzzi G
    Curr Protoc Toxicol; 2010 Feb; Chapter 21():Unit 21.1. PubMed ID: 20967743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial modulation of the gut microbiota.
    Walsh CJ; Guinane CM; O'Toole PW; Cotter PD
    FEBS Lett; 2014 Nov; 588(22):4120-30. PubMed ID: 24681100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution of lipids from mucus: a possible mechanism for prompt disruption of gut barrier function by alcohol.
    Qin X; Deitch EA
    Toxicol Lett; 2015 Jan; 232(2):356-62. PubMed ID: 25445722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.
    Chassaing B; Koren O; Goodrich JK; Poole AC; Srinivasan S; Ley RE; Gewirtz AT
    Nature; 2015 Mar; 519(7541):92-6. PubMed ID: 25731162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the intestinal microbiota in programming health and disease.
    Goulet O
    Nutr Rev; 2015 Aug; 73 Suppl 1():32-40. PubMed ID: 26175488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.